Qingfeng Li

406 total citations
15 papers, 277 citations indexed

About

Qingfeng Li is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Qingfeng Li has authored 15 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Qingfeng Li's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and Long-Term Effects of COVID-19 (4 papers). Qingfeng Li is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and Long-Term Effects of COVID-19 (4 papers). Qingfeng Li collaborates with scholars based in China, Belgium and Australia. Qingfeng Li's co-authors include Yilan Zeng, Ming Yang, Hong Chen, Ru Liu, Hong Xu, Dan Wang, Na Zhang, Piet Herdewijn, Elisabetta Groaz and Leentje Persoons and has published in prestigious journals such as The Journal of Organic Chemistry, Tetrahedron and Frontiers in Microbiology.

In The Last Decade

Qingfeng Li

14 papers receiving 273 citations

Peers

Qingfeng Li
Yujuan Guan China
Rameswari Chilamakuri United States
Valeria Filippi Italy
Vladimir E. Nebolsin Russia
Thomas Hills New Zealand
Xin Tan China
Xixian Zhao China
Sajjad Biglari Iran
Murugan Natarajan India
Alfonso Masullo Italy
Yujuan Guan China
Qingfeng Li
Citations per year, relative to Qingfeng Li Qingfeng Li (= 1×) peers Yujuan Guan

Countries citing papers authored by Qingfeng Li

Since Specialization
Citations

This map shows the geographic impact of Qingfeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Li more than expected).

Fields of papers citing papers by Qingfeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Li. The network helps show where Qingfeng Li may publish in the future.

Co-authorship network of co-authors of Qingfeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfeng Li. A scholar is included among the top collaborators of Qingfeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfeng Li. Qingfeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chen, Zhuo, Lianpeng Wu, Xiuting Chen, et al.. (2024). A novel HBc-S230 protein chimeric VLPs induced robust immune responses against SARS-CoV-2. International Immunopharmacology. 143(Pt 2). 113362–113362.
2.
Zhou, Ruifeng, Tianli Zheng, Dongxia Luo, et al.. (2022). Drug resistance characteristics of Mycobacterium tuberculosis isolates obtained between 2018 and 2020 in Sichuan, China. Epidemiology and Infection. 150. e27–e27. 15 indexed citations
3.
Wu, Lianpeng, Zhuo Chen, Qingfeng Li, et al.. (2022). Nucleocapsid protein of SARS‐CoV‐2 is a potential target for developing new generation of vaccine. Journal of Clinical Laboratory Analysis. 36(6). e24479–e24479. 35 indexed citations
4.
Jiang, Peipei, Qingfeng Li, Wen He, et al.. (2022). Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants. Microbiology Spectrum. 11(1). e0356222–e0356222. 5 indexed citations
5.
Wang, Yong, Yaling Liu, Lei Bao, et al.. (2021). Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus. Diabetology & Metabolic Syndrome. 13(1). 5–5. 10 indexed citations
6.
Du, Jian, Jingtao Gao, Qingfeng Li, et al.. (2021). Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination. Frontiers in Microbiology. 12. 655653–655653. 15 indexed citations
7.
8.
Xu, Yuanhong, Qingfeng Li, Dongmei Wang, et al.. (2020). The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015–2018. Medicine. 99(43). e22608–e22608. 7 indexed citations
9.
Li, Qingfeng, Elisabetta Groaz, Joana Rocha‐Pereira, Johan Neyts, & Piet Herdewijn. (2020). Anti-norovirus activity of C7-modified 4-amino-pyrrolo[2,1-f][1,2,4]triazine C-nucleosides. European Journal of Medicinal Chemistry. 195. 112198–112198. 16 indexed citations
10.
Xu, Hong, Ming Yang, Yilan Zeng, et al.. (2020). Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu. Journal of Clinical Virology. 127. 104366–104366. 128 indexed citations
11.
Li, Qingfeng, Elisabetta Groaz, Leentje Persoons, Dirk Daelemans, & Piet Herdewijn. (2020). Synthesis and Antitumor Activity of C-7-Alkynylated and Arylated Pyrrolotriazine C-Ribonucleosides. ACS Medicinal Chemistry Letters. 11(8). 1605–1610. 6 indexed citations
12.
Zhou, Mi, Jing Zhong, Lei Bi, et al.. (2020). Serological characteristics of COVID-19 patients. Infectious Diseases. 52(10). 749–750. 2 indexed citations
13.
Li, Qingfeng, Elisabetta Groaz, & Piet Herdewijn. (2019). Synthesis of tetradialdose phosphonate nucleosides as mimics of l-nucleotides. Tetrahedron. 75(37). 130497–130497. 2 indexed citations
14.
Li, Qingfeng, Leentje Persoons, Dirk Daelemans, & Piet Herdewijn. (2019). Iron/Copper Co-Catalyzed Cross-Coupling Reaction for the Synthesis of 6-Substituted 7-Deazapurines and the Corresponding Nucleosides. The Journal of Organic Chemistry. 85(2). 403–418. 16 indexed citations
15.
Li, Qingfeng, Eveline Lescrinier, Elisabetta Groaz, et al.. (2017). Synthesis and Biological Evaluation of Pyrrolo[2,1‐f][1,2,4]triazine C‐Nucleosides with a Ribose, 2′‐Deoxyribose, and 2′,3′‐Dideoxyribose Sugar Moiety. ChemMedChem. 13(1). 97–104. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yujuan Guan Breakdown of academic impact, for papers by Rameswari Chilamakuri Breakdown of academic impact, for papers by Valeria Filippi Breakdown of academic impact, for papers by Vladimir E. Nebolsin Breakdown of academic impact, for papers by Thomas Hills Breakdown of academic impact, for papers by Xin Tan Breakdown of academic impact, for papers by Xixian Zhao Breakdown of academic impact, for papers by Sajjad Biglari Breakdown of academic impact, for papers by Murugan Natarajan Breakdown of academic impact, for papers by Alfonso Masullo
Rankless by CCL
2026